Marrone Bio Innovations

Marrone Bio Innovations sets record in Q-3 financials

Marrone Bio Innovatons (MBII-NASDAQ) CEO Marrone joined Steve Darling from Proactive Investors at the LD MIcro Show in Los Angeles to talk about the success her company has seen especially in Q-3. That success has come from some changes and some key hiring. The company is a a leading provider of bio-based pest management. Dr Marrone also told Proactive about two major awards the company won this year. 

Quick facts: Marrone Bio Innovations

Price: $1.48

Market: NASDAQ
Market Cap: $182.67 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...



Full interview: Marrone Bio broadens distribution network into Europe with...

Marrone Bio Innovations Inc (NASDAQ:MBII) CEO Pam Marrone tells Proactive the California-based company has closed on its acquisition of Finland-based Pro Farm Technologies OY. Marrone says this $31.8 million deal adds nutrient and biostimulant technology to its portfolio as well as products...

5 days, 22 hours ago

2 min read